Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,536 studies match

clinicaltrialsPublishedShowing 651–700 of 1,536 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04700072	Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)	completed	Phase 1 / Phase 2	56	Merck Sharp & Dohme LLCINDUSTRY	8	Oct 28, 2025	clinicaltrials
NCT04385277	Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)	active not recruiting	Phase 2	41	Children's Oncology GroupNETWORK